Influence of Acetylator Phenotype on Antidepressant Effects of Phenelzine
- 31 August 1982
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 141 (3) , 243-248
- https://doi.org/10.1192/bjp.141.3.243
Abstract
Summary: Acetylator phenotype, determined by blood levels after sulphadimidine, was related to outcome in a controlled trial of phenelzine in patients with depression and mixed anxiety depression. Slow acetylators showed more improvement and greater phenelzine-placebo differences than did fast acetylators, at two, four and six weeks. A tendency towards faster acetylation was observed in subjects with previous increased alcohol intake. Acetylator phenotype was not related to other symptom, diagnostic or history data.This publication has 19 references indexed in Scilit:
- Response to Phenelzine and Amitriptyline in Subtypes of Outpatient DepressionArchives of General Psychiatry, 1982
- The influence of acetylator phenotype on the outcome of treatment with phenelzine, in a clinical trial.British Journal of Clinical Pharmacology, 1978
- Clinical Pharmacology of PhenelzineArchives of General Psychiatry, 1978
- The myth of phenelzine acetylation.BMJ, 1976
- A Multiple-Dose, Controlled Study of Phenelzine in Depression-Anxiety StatesArchives of General Psychiatry, 1976
- The Efficacy of Antidepressant DrugsArchives of General Psychiatry, 1974
- The Hopkins Symptom Checklist (HSCL): A self-report symptom inventoryBehavioral Science, 1974
- Differential Response to Chlorpromazine, Imipramine, and PlaceboArchives of General Psychiatry, 1970
- An improved and simplified method of detecting the acetylator phenotype.Journal of Medical Genetics, 1969
- The Brief Psychiatric Rating ScalePsychological Reports, 1962